subject: Anti-obesity Drug Pipeline Analysis And Market Forecasts To 2016---aarkstore Enterprise Market [print this page] Anti-Obesity - Drug Pipeline Analysis and Market Forecasts to 2016
Summary
The industry analysis specialists new report on the pharmaceutical and healthcare sector, Anti-Obesity - Drug Pipeline Analysis and Market Forecasts to 2016 is an essential source of information and analysis on the global anti-obesity market. The report identifies the key trends shaping and driving the global anti- obesity market, a key segment within the pharma industry. The report also provides insight on the prevalent competitive landscape and the emerging players expected to bring significant shift in the market positioning of the existing market leaders. Most importantly, the report provides valuable insight on the pipeline products within the global anti-obesity sector.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by team of industry experts.
Scope
The scope of the report includes:
* Annualized global anti-obesity market revenues data from 2001 to 2009, forecast forward for seven years to 2016.
* Geographies covered in this report include the US, the UK, Italy, Spain, Germany, France, and Japan.
* Pipeline analysis data providing a split across different phases, mechanisms of action being developed, and emerging trends. The pipeline candidates fall under the major categories such as appetite suppressants, calorie/fat absorption inhibitors, metabolism boosters and combination drugs.
* Analysis of the current and future market competition in the global anti-obesity market. Key future market players covered are Orexigen Therapeutics, Arena Pharmaceuticals, and Vivus, Inc. which holds some of the most promising molecules that have demonstrated greater efficacy or safety or both. In addition, companies such as Alizyme Therapeutics, and NeuroSearch A/S are found to be the companies with noticeable Phase III molecules.
* Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.
* Key topics covered include strategic competitor assessment, market characterization, unmet needs and implications for the future market associated with anti-obesity.
